10 results
10-K
2023 FY
TSBX
Turnstone Biologics Corp.
21 Mar 24
Annual report
8:51pm
” and proxy access. Emerging growth companies and smaller reporting companies are exempted from certain of these requirements, but we may be required
10-Q
2023 Q2
TSBX
Turnstone Biologics Corp.
1 Sep 23
Quarterly report
4:39pm
related provisions in the Dodd-Frank Act that require the SEC to adopt additional rules and regulations in these areas such as “say on pay” and proxy access. Emerging
424B4
j006uox7
21 Jul 23
Prospectus supplement with pricing info
7:14pm
S-1/A
3itl1t8vc61d1
23 Jun 23
IPO registration (amended)
9:49pm
S-1
2bf o9ck4ec
12 Jun 23
IPO registration
4:28pm
DRS
z0759qtgjb928g16pv
15 May 23
Draft registration statement
12:00am
- Prev
- 1
- Next